Campistol, M.; Morote, J.; Triquell, M.; Regis, L.; Celma, A.; de Torres, I.; Semidey, M.E.; Mast, R.; SantamarÃa, A.; Planas, J.;
et al. Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI. Cancers 2022, 14, 2702.
https://doi.org/10.3390/cancers14112702
AMA Style
Campistol M, Morote J, Triquell M, Regis L, Celma A, de Torres I, Semidey ME, Mast R, SantamarÃa A, Planas J,
et al. Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI. Cancers. 2022; 14(11):2702.
https://doi.org/10.3390/cancers14112702
Chicago/Turabian Style
Campistol, Miriam, Juan Morote, Marina Triquell, Lucas Regis, Ana Celma, Inés de Torres, MarÃa E. Semidey, Richard Mast, Anna SantamarÃa, Jacques Planas,
and et al. 2022. "Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI" Cancers 14, no. 11: 2702.
https://doi.org/10.3390/cancers14112702
APA Style
Campistol, M., Morote, J., Triquell, M., Regis, L., Celma, A., de Torres, I., Semidey, M. E., Mast, R., SantamarÃa, A., Planas, J., & Trilla, E.
(2022). Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI. Cancers, 14(11), 2702.
https://doi.org/10.3390/cancers14112702
